Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Michael A. Metzger$1.8B
Market Cap • 19/04/20242005
(há 19 anos)
2016
(8 years ago)
NASDAQ
Listagem
Waltham
Sede • Massachusetts107
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
SNDXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.